Labcorp
About: Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
Employees: 70,000
0
Funds holding %
of 7,429 funds
0
Analysts bullish %
of 6 analysts
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
109% more call options, than puts
Call options by funds: $47.8M | Put options by funds: $22.9M
18% more first-time investments, than exits
New positions opened: 105 | Existing positions closed: 89
17% more capital invested
Capital invested by funds: $17.8B [Q1] → $20.8B (+$2.99B) [Q2]
3.23% more ownership
Funds ownership: 91.63% [Q1] → 94.86% (+3.23%) [Q2]
0% more funds holding in top 10
Funds holding in top 10: 13 [Q1] → 13 (+0) [Q2]
1% less funds holding
Funds holding: 958 [Q1] → 953 (-5) [Q2]
6% less repeat investments, than reductions
Existing positions increased: 334 | Existing positions reduced: 356
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$275
0%
upside
Avg. target
$300
9%
upside
High target
$310
12%
upside
6 analyst ratings
5 positive
83%
1 neutral
17%
0 negative
0%
Truist Securities David Macdonald | 12%upside $310 | Buy Maintained | 25 Jul 2025 |
UBS Kevin Caliendo | 10%upside $305 | Buy Maintained | 25 Jul 2025 |
Evercore ISI Group Elizabeth Anderson | 9%upside $300 | Outperform Maintained | 25 Jul 2025 |
Morgan Stanley Ricky Goldwasser | 11%upside $306 | Overweight Maintained | 25 Jul 2025 |
Baird Eric Coldwell | 9%upside $302 | Outperform Maintained | 25 Jul 2025 |
Financial journalist opinion
Based on 9 articles about LH published over the past 30 days
Positive
Zacks Investment Research
5 days ago
Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Positive
Zacks Investment Research
6 days ago
Why Labcorp Holdings (LH) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Positive
Zacks Investment Research
6 days ago
Labcorp Debuts First FDA-Cleared Blood Test for Alzheimer's, Stock Up
LH launches the first FDA-cleared blood test for Alzheimer's, boosting access to early diagnosis and nudging its stock higher.
Neutral
PRNewsWire
1 week ago
Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease
Lumipulse® pTau-217/Beta Amyloid 42 Ratio now available nationwide through Labcorp BURLINGTON, N.C. , Aug. 18, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the availability of the Lumipulse® pTau-217/Beta Amyloid 42 Ratio, the first blood-based in-vitro diagnostic (IVD) test cleared by the U.S. Food and Drug Administration (FDA) to aid in the diagnosis of Alzheimer's disease through early detection of the amyloid plaques associated with the disease in appropriate patients.
Positive
Zacks Investment Research
1 week ago
Here's Why Labcorp Holdings (LH) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Positive
Zacks Investment Research
3 weeks ago
Why Labcorp Holdings (LH) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Neutral
PRNewsWire
3 weeks ago
Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search
Test Finder interprets provider questions in context to deliver curated, clinically relevant results, going beyond traditional search Developed in collaboration with Amazon Web Services, Test Finder is now available on Labcorp.com BURLINGTON, N.C. , July 30, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Test Finder, a first-of-its-kind generative AI tool developed with Amazon Web Services (AWS).
Positive
Zacks Investment Research
3 weeks ago
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Neutral
PRNewsWire
4 weeks ago
Labcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EU
First-and-only test of its kind approved under new European Union regulations expands access to personalized cancer care for patients across the EU BURLINGTON, N.C. , July 29, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today PGDx elio™ tissue complete has been CE-marked under the European Union's (EU) new In Vitro Diagnostic Regulation (IVDR).
Positive
Benzinga
1 month ago
These Analysts Boost Their Forecasts On Labcorp Following Better-Than-Expected Q2 Earnings
Labcorp Holdings Inc. LH on Thursday reported stronger-than-expected results for the second quarter.
Charts implemented using Lightweight Charts™